Remove FDA Remove Pharma Remove Prescription Remove Side effects
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The FDA needs to study what people do when they see a DTC ad. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. DTC ads raise awareness around health conditions.

Marketing 285
article thumbnail

A realistic view of healthcare in 2022

World of DTC Marketing

1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. People don’t want to lose weight through diet and exercise if they can lose it through a prescription drug.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DTC marketing is an oxymoron

World of DTC Marketing

Product websites are stagnant, and online health seekers are going elsewhere to learn about your medication’s side effects and cost. A website and TV commercials are not enough to get patients to ask for a prescription medication especially when fair balance lists side effects like cancer.

Marketing 265
article thumbnail

A scientific approach to irrational consumer choices

World of DTC Marketing

GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. Ad recall is essential for CPGs, but for prescription drugs, the question that’s missing is “what action did it lead to?

article thumbnail

Thursday pharma headlines

World of DTC Marketing

prescriptions of finasteride, as the drug is known, for hair loss increased to over 2.4 Food and Drug Administration (FDA) is meant to help patients and warn of potential drug side effects but a Vice report indicates something more. The post Thursday pharma headlines appeared first on World of DTC Marketing.com.

Pharma 180
article thumbnail

FDA rejects Spectrum’s lung cancer drug poziotinib

pharmaphorum

The FDA has issued a complete response letter (CRL) to Spectrum Pharma for poziotinib, its pan HER2 inhibitor for a form of lung cancer, according to South Korea’s Hanmi Pharma, which originally developed the drug. The post FDA rejects Spectrum’s lung cancer drug poziotinib appeared first on.

FDA 98
article thumbnail

Elements of a great pharma website

World of DTC Marketing

In clinical trials, how many people experienced a listed side effect? They understand that patient content could be edited to meet FDA requirements, but they like reading others’ experiences managing their health issues. 9ine: “Why aren’t pharma websites updated?” 7even: Real patient stories.

Pharma 180